Published in J Med Genet on March 01, 2004
Cellular and molecular mechanisms of pain. Cell (2009) 9.36
A gain-of-function mutation in TRPA1 causes familial episodic pain syndrome. Neuron (2010) 3.31
Inherited disorders of voltage-gated sodium channels. J Clin Invest (2005) 3.29
Sodium channel mutations in epilepsy and other neurological disorders. J Clin Invest (2005) 3.17
Nociceptor-specific gene deletion reveals a major role for Nav1.7 (PN1) in acute and inflammatory pain. Proc Natl Acad Sci U S A (2004) 3.07
Validating therapeutic targets through human genetics. Nat Rev Drug Discov (2013) 2.94
The Na(V)1.7 sodium channel: from molecule to man. Nat Rev Neurosci (2012) 2.71
Multiple sodium channels and their roles in electrogenesis within dorsal root ganglion neurons. J Physiol (2006) 2.62
A single sodium channel mutation produces hyper- or hypoexcitability in different types of neurons. Proc Natl Acad Sci U S A (2006) 2.61
Mutations in sodium-channel gene SCN9A cause a spectrum of human genetic pain disorders. J Clin Invest (2007) 2.58
A role of SCN9A in human epilepsies, as a cause of febrile seizures and as a potential modifier of Dravet syndrome. PLoS Genet (2009) 2.12
The roles of sodium channels in nociception: Implications for mechanisms of pain. Pain (2007) 2.06
Exome sequencing reveals mutations in TRPV3 as a cause of Olmsted syndrome. Am J Hum Genet (2012) 1.91
Neuropathic pain develops normally in mice lacking both Na(v)1.7 and Na(v)1.8. Mol Pain (2005) 1.86
Pain perception is altered by a nucleotide polymorphism in SCN9A. Proc Natl Acad Sci U S A (2010) 1.79
Distinct Nav1.7-dependent pain sensations require different sets of sensory and sympathetic neurons. Nat Commun (2012) 1.72
Principles of early drug discovery. Br J Pharmacol (2011) 1.68
Mechanisms and management of diabetic painful distal symmetrical polyneuropathy. Diabetes Care (2013) 1.62
Neurological perspectives on voltage-gated sodium channels. Brain (2012) 1.62
Spider-venom peptides as therapeutics. Toxins (Basel) (2010) 1.44
Progress in genetic studies of pain and analgesia. Annu Rev Pharmacol Toxicol (2009) 1.43
A Nav1.7 channel mutation associated with hereditary erythromelalgia contributes to neuronal hyperexcitability and displays reduced lidocaine sensitivity. J Physiol (2007) 1.35
Pain as a channelopathy. J Clin Invest (2010) 1.33
Paroxysmal extreme pain disorder M1627K mutation in human Nav1.7 renders DRG neurons hyperexcitable. Mol Pain (2008) 1.26
Pain genes. PLoS Genet (2008) 1.23
Sodium channelopathies and pain. Pflugers Arch (2010) 1.22
Mutation I136V alters electrophysiological properties of the Na(v)1.7 channel in a family with onset of erythromelalgia in the second decade. Mol Pain (2008) 1.21
Immortalization and characterization of a nociceptive dorsal root ganglion sensory neuronal line. J Peripher Nerv Syst (2007) 1.16
Genetic basis of pain variability: recent advances. J Med Genet (2011) 1.14
Gain-of-function mutations in SCN11A cause familial episodic pain. Am J Hum Genet (2013) 1.14
The red ear syndrome. J Headache Pain (2013) 1.13
Continuous delta-opioid receptor activation reduces neuronal voltage-gated sodium channel (NaV1.7) levels through activation of protein kinase C in painful diabetic neuropathy. J Neurosci (2008) 1.13
Discovery of a selective NaV1.7 inhibitor from centipede venom with analgesic efficacy exceeding morphine in rodent pain models. Proc Natl Acad Sci U S A (2013) 1.11
Pain channelopathies. J Physiol (2010) 1.09
A brief comparison of the pathophysiology of inflammatory versus neuropathic pain. Curr Opin Anaesthesiol (2011) 1.08
Expression of Nav1.7 in DRG neurons extends from peripheral terminals in the skin to central preterminal branches and terminals in the dorsal horn. Mol Pain (2012) 1.07
Characterization of a familial case with primary erythromelalgia from Taiwan. J Neurol (2007) 1.05
Can robots patch-clamp as well as humans? Characterization of a novel sodium channel mutation. J Physiol (2010) 1.03
Congenital insensitivity to pain: novel SCN9A missense and in-frame deletion mutations. Hum Mutat (2010) 1.03
Defective fast inactivation recovery of Nav 1.4 in congenital myasthenic syndrome. Ann Neurol (2015) 1.02
Global Nav1.7 knockout mice recapitulate the phenotype of human congenital indifference to pain. PLoS One (2014) 1.02
Nav1.7 expression is increased in painful human dental pulp. Mol Pain (2008) 1.00
Effects of ranolazine on wild-type and mutant hNav1.7 channels and on DRG neuron excitability. Mol Pain (2010) 0.97
Temperature dependence of erythromelalgia mutation L858F in sodium channel Nav1.7. Mol Pain (2007) 0.96
Two novel mutations of SCN9A (Nav1.7) are associated with partial congenital insensitivity to pain. Eur J Pain (2010) 0.95
Fever-triggered ventricular arrhythmias in Brugada syndrome and type 2 long-QT syndrome. Neth Heart J (2010) 0.94
Genes and epigenetic processes as prospective pain targets. Genome Med (2013) 0.93
Seeing the forest through the trees: towards a unified view on physiological calcium regulation of voltage-gated sodium channels. Biophys J (2012) 0.92
A novel SCN9A mutation responsible for primary erythromelalgia and is resistant to the treatment of sodium channel blockers. PLoS One (2013) 0.92
Late-onset erythromelalgia in a previously healthy young woman: a case report and review of the literature. J Med Case Rep (2009) 0.91
Sodium channel blockers for the treatment of neuropathic pain. Neurotherapeutics (2009) 0.91
Challenges in the development of novel treatment strategies for neuropathic pain. NeuroRx (2005) 0.90
Molecular cloning and analysis of zebrafish voltage-gated sodium channel beta subunit genes: implications for the evolution of electrical signaling in vertebrates. BMC Evol Biol (2007) 0.90
Nature and nurture of human pain. Scientifica (Cairo) (2013) 0.89
Infrequent SCN9A mutations in congenital insensitivity to pain and erythromelalgia. J Neurol Neurosurg Psychiatry (2012) 0.89
Enhanced excitability of primary sensory neurons and altered gene expression of neuronal ion channels in dorsal root ganglion in paclitaxel-induced peripheral neuropathy. Anesthesiology (2014) 0.89
Subtype-Selective Small Molecule Inhibitors Reveal a Fundamental Role for Nav1.7 in Nociceptor Electrogenesis, Axonal Conduction and Presynaptic Release. PLoS One (2016) 0.88
The clinical approach to small fibre neuropathy and painful channelopathy. Pract Neurol (2014) 0.87
Voltage gated sodium channels as drug discovery targets. Channels (Austin) (2015) 0.87
Seven novel modulators of the analgesic target NaV 1.7 uncovered using a high-throughput venom-based discovery approach. Br J Pharmacol (2015) 0.87
Novel mutations mapping to the fourth sodium channel domain of Nav1.7 result in variable clinical manifestations of primary erythromelalgia. Neuromolecular Med (2013) 0.87
Therapeutic Approaches to Genetic Ion Channelopathies and Perspectives in Drug Discovery. Front Pharmacol (2016) 0.86
Genetic neurological channelopathies: molecular genetics and clinical phenotypes. J Neurol Neurosurg Psychiatry (2015) 0.85
Classification and diagnosis of the inherited neuropathies. Ann Indian Acad Neurol (2009) 0.85
Na(+) channel blockers for the treatment of pain: context is everything, almost. Exp Neurol (2007) 0.85
Nav1.7 and other voltage-gated sodium channels as drug targets for pain relief. Expert Opin Ther Targets (2016) 0.84
Reduction of voltage gated sodium channel protein in DRG by vector mediated miRNA reduces pain in rats with painful diabetic neuropathy. Mol Pain (2012) 0.84
Cold-aggravated pain in humans caused by a hyperactive NaV1.9 channel mutant. Nat Commun (2015) 0.84
Synthetic ciguatoxins selectively activate Nav1.8-derived chimeric sodium channels expressed in HEK293 cells. J Biol Chem (2009) 0.83
Pharmacogenetics of analgesic drugs. Br J Pain (2013) 0.83
Neuropathic pain. Nat Rev Dis Prim (2017) 0.82
Genistein inhibits voltage-gated sodium currents in SCG neurons through protein tyrosine kinase-dependent and kinase-independent mechanisms. Pflugers Arch (2008) 0.82
Analysis of the structural and molecular basis of voltage-sensitive sodium channel inhibition by the spider toxin huwentoxin-IV (μ-TRTX-Hh2a). J Biol Chem (2013) 0.82
A nonsense mutation in the SCN9A gene in congenital insensitivity to pain. Dermatology (2010) 0.82
A large temperature fluctuation may trigger an epidemic erythromelalgia outbreak in China. Sci Rep (2015) 0.82
Compound heterozygosity in sodium channel Nav1.7 in a family with hereditary erythermalgia. Mol Pain (2008) 0.82
Novel mRNA isoforms of the sodium channels Na(v)1.2, Na(v)1.3 and Na(v)1.7 encode predicted two-domain, truncated proteins. Neuroscience (2008) 0.82
Extending the clinical spectrum of pain channelopathies. Brain (2012) 0.82
Three Peptide Modulators of the Human Voltage-Gated Sodium Channel 1.7, an Important Analgesic Target, from the Venom of an Australian Tarantula. Toxins (Basel) (2015) 0.82
Erythromelalgia mutation Q875E Stabilizes the activated state of sodium channel Nav1.7. J Biol Chem (2015) 0.81
Protective alleles and modifier variants in human health and disease. Nat Rev Genet (2015) 0.81
Post-translational modifications of voltage-gated sodium channels in chronic pain syndromes. Front Pharmacol (2015) 0.80
Infantile Pain Episodes Associated with Novel Nav1.9 Mutations in Familial Episodic Pain Syndrome in Japanese Families. PLoS One (2016) 0.80
Linkage between increased nociception and olfaction via a SCN9A haplotype. PLoS One (2013) 0.80
The perception and endogenous modulation of pain. Scientifica (Cairo) (2012) 0.80
Optical electrophysiology for probing function and pharmacology of voltage-gated ion channels. Elife (2016) 0.79
Congenital insensitivity to pain: a case report and review of the literature. Case Rep Neurol Med (2014) 0.79
Erythromelalgia? A clinical study of people who experience red, hot, painful feet in the community. Int J Vasc Med (2013) 0.79
Splice variants of Na(V)1.7 sodium channels have distinct β subunit-dependent biophysical properties. PLoS One (2012) 0.79
Nav1.7 protein and mRNA expression in the dorsal root ganglia of rats with chronic neuropathic pain. Neural Regen Res (2012) 0.79
Experience with oral mexiletine in primary erythromelalgia in children. Ann Saudi Med (2009) 0.79
Erythema and burning pain in the vulva: a possible phenotype of erythromelalgia. Case Rep Med (2011) 0.79
Molecular architecture of a sodium channel S6 helix: radial tuning of the voltage-gated sodium channel 1.7 activation gate. J Biol Chem (2013) 0.78
Pharmacological characterisation of the highly NaV1.7 selective spider venom peptide Pn3a. Sci Rep (2017) 0.78
SCN10A Mutation in a Patient with Erythromelalgia Enhances C-Fiber Activity Dependent Slowing. PLoS One (2016) 0.77
A case of primary erythermalgia with encephalopathy. J Neurol (2009) 0.77
Regulation of Nav1.7: A Conserved SCN9A Natural Antisense Transcript Expressed in Dorsal Root Ganglia. PLoS One (2015) 0.77
What activates inactivation? J Gen Physiol (2013) 0.77
Engineering Highly Potent and Selective Microproteins against Nav1.7 Sodium Channel for Treatment of Pain. J Biol Chem (2016) 0.77
Analysis of the mouse transcriptome based on functional annotation of 60,770 full-length cDNAs. Nature (2002) 28.79
Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet (2005) 24.57
Gene transfer into mouse lyoma cells by electroporation in high electric fields. EMBO J (1982) 17.98
Genome sequence of an obligate intracellular pathogen of humans: Chlamydia trachomatis. Science (1998) 13.64
Inflammation and Alzheimer's disease. Neurobiol Aging (2000) 12.56
Complete genome sequence of Methanobacterium thermoautotrophicum deltaH: functional analysis and comparative genomics. J Bacteriol (1997) 12.21
p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. Mol Cell (1998) 11.54
SKP1 connects cell cycle regulators to the ubiquitin proteolysis machinery through a novel motif, the F-box. Cell (1996) 11.22
Mutations of the VHL tumour suppressor gene in renal carcinoma. Nat Genet (1994) 10.14
Modular chemistry: secondary building units as a basis for the design of highly porous and robust metal-organic carboxylate frameworks. Acc Chem Res (2001) 9.19
The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. Diabetes Care (1999) 9.16
WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res (1994) 9.00
Regulatory element detection using correlation with expression. Nat Genet (2001) 8.92
Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med (2000) 8.47
The interaction between N-WASP and the Arp2/3 complex links Cdc42-dependent signals to actin assembly. Cell (1999) 8.07
Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science (1997) 7.95
The frequency of chimeric molecules as a consequence of PCR co-amplification of 16S rRNA genes from different bacterial species. Microbiology (1996) 7.78
The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N Engl J Med (2000) 7.54
Neuroligin expressed in nonneuronal cells triggers presynaptic development in contacting axons. Cell (2000) 7.48
Isochorismate synthase is required to synthesize salicylic acid for plant defence. Nature (2001) 7.43
A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small-cell lung cancer. N Engl J Med (1994) 7.25
Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate. Neuron (1996) 7.20
Notch signalling controls pancreatic cell differentiation. Nature (1999) 7.18
Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease. Am J Pathol (1999) 7.16
Crystal structure of a T-cell receptor beta-chain complexed with a superantigen. Nature (1996) 7.11
Frequency of formation of chimeric molecules as a consequence of PCR coamplification of 16S rRNA genes from mixed bacterial genomes. Appl Environ Microbiol (1997) 7.09
Refined structure of alpha beta-tubulin at 3.5 A resolution. J Mol Biol (2001) 7.08
A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat Med (2000) 7.05
A new member of the frizzled family from Drosophila functions as a Wingless receptor. Nature (1996) 7.04
Requirement of ATM-dependent phosphorylation of brca1 in the DNA damage response to double-strand breaks. Science (1999) 6.93
Whole-genome association study of bipolar disorder. Mol Psychiatry (2008) 6.80
Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT. Nat Genet (1997) 6.69
PKD2, a gene for polycystic kidney disease that encodes an integral membrane protein. Science (1996) 6.56
Assembly and analysis of conical models for the HIV-1 core. Science (1999) 6.35
TFAR19, a novel apoptosis-related gene cloned from human leukemia cell line TF-1, could enhance apoptosis of some tumor cells induced by growth factor withdrawal. Biochem Biophys Res Commun (1999) 6.33
Prevention of neural-tube defects with folic acid in China. China-U.S. Collaborative Project for Neural Tube Defect Prevention. N Engl J Med (1999) 6.27
Mechanical unfolding intermediates in titin modules. Nature (1999) 6.12
Readmission after hospitalization for congestive heart failure among Medicare beneficiaries. Arch Intern Med (1997) 5.93
Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells. Oncogene (2006) 5.86
Comparative genomes of Chlamydia pneumoniae and C. trachomatis. Nat Genet (1999) 5.81
A cluster of hydrophobic amino acid residues required for fast Na(+)-channel inactivation. Proc Natl Acad Sci U S A (1992) 5.60
Leptomycin B is an inhibitor of nuclear export: inhibition of nucleo-cytoplasmic translocation of the human immunodeficiency virus type 1 (HIV-1) Rev protein and Rev-dependent mRNA. Chem Biol (1997) 5.49
Deficient hippocampal long-term potentiation in alpha-calcium-calmodulin kinase II mutant mice. Science (1992) 5.46
Blood transfusion in elderly patients with acute myocardial infarction. N Engl J Med (2001) 5.43
IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs. Cancer Res (1998) 5.41
Genetic diversity and disease control in rice. Nature (2000) 5.34
A role for the lissencephaly gene LIS1 in mitosis and cytoplasmic dynein function. Nat Cell Biol (2000) 5.29
Racial differences in the use of cardiac catheterization after acute myocardial infarction. N Engl J Med (2001) 5.29
Organizing principles for a diversity of GABAergic interneurons and synapses in the neocortex. Science (2000) 5.27
MyD88: an adapter that recruits IRAK to the IL-1 receptor complex. Immunity (1997) 5.23
A major role for VCAM-1, but not ICAM-1, in early atherosclerosis. J Clin Invest (2001) 4.98
Isolation of a Miller-Dieker lissencephaly gene containing G protein beta-subunit-like repeats. Nature (1993) 4.87
An rpsL cassette, janus, for gene replacement through negative selection in Streptococcus pneumoniae. Appl Environ Microbiol (2001) 4.59
Differential signaling via the same axon of neocortical pyramidal neurons. Proc Natl Acad Sci U S A (1998) 4.59
POWER_SAGE: comparing statistical tests for SAGE experiments. Bioinformatics (2000) 4.56
BACE1 is the major beta-secretase for generation of Abeta peptides by neurons. Nat Neurosci (2001) 4.54
KILLER/DR5 is a DNA damage-inducible p53-regulated death receptor gene. Nat Genet (1997) 4.46
Proteolytic refolding of the HIV-1 capsid protein amino-terminus facilitates viral core assembly. EMBO J (1998) 4.46
Vitamin C pharmacokinetics in healthy volunteers: evidence for a recommended dietary allowance. Proc Natl Acad Sci U S A (1996) 4.45
A mouse model for spinal muscular atrophy. Nat Genet (2000) 4.37
Myogenin gene disruption results in perinatal lethality because of severe muscle defect. Nature (1993) 4.33
Do "America's Best Hospitals" perform better for acute myocardial infarction? N Engl J Med (1999) 4.30
Human cytomegalovirus IE1 and IE2 proteins block apoptosis. J Virol (1995) 4.22
Recovery from psychotic illness: a 15- and 25-year international follow-up study. Br J Psychiatry (2001) 4.13
Neutralizing antibody responses in acute human immunodeficiency virus type 1 subtype C infection. J Virol (2007) 4.13
Identification of peptide and protein ligands for the caveolin-scaffolding domain. Implications for the interaction of caveolin with caveolae-associated proteins. J Biol Chem (1997) 4.12
Fringe is a glycosyltransferase that modifies Notch. Nature (2000) 4.09
Broadly protective vaccine for Staphylococcus aureus based on an in vivo-expressed antigen. Science (1999) 4.08
Suppression of Raf-1 kinase activity and MAP kinase signalling by RKIP. Nature (1999) 3.99
Mechanisms underlying endothelial dysfunction in diabetes mellitus. Circ Res (2001) 3.89
Microdeletion/duplication at 15q13.2q13.3 among individuals with features of autism and other neuropsychiatric disorders. J Med Genet (2008) 3.87
Molecular cloning of cDNA for double-stranded RNA adenosine deaminase, a candidate enzyme for nuclear RNA editing. Proc Natl Acad Sci U S A (1994) 3.85
Tracing the stepwise oxygenation of the Proterozoic ocean. Nature (2008) 3.85
Notch4/int-3, a mammary proto-oncogene, is an endothelial cell-specific mammalian Notch gene. Development (1996) 3.84
Visual acuity and quality of life in patients with cataract in Doumen County, China. Ophthalmology (1999) 3.82
PDGF-C is a new protease-activated ligand for the PDGF alpha-receptor. Nat Cell Biol (2000) 3.81
Dissecting the interaction between nitric oxide synthase (NOS) and caveolin. Functional significance of the nos caveolin binding domain in vivo. J Biol Chem (1997) 3.80
Superconductivity at 43 K in SmFeAsO1-xFx. Nature (2008) 3.80
Pleiotropic defects in ataxia-telangiectasia protein-deficient mice. Proc Natl Acad Sci U S A (1996) 3.78
Patterns of vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 expression in rabbit and mouse atherosclerotic lesions and at sites predisposed to lesion formation. Circ Res (1999) 3.69
Follicle stimulating hormone is required for ovarian follicle maturation but not male fertility. Nat Genet (1997) 3.69
The presynaptic particle web: ultrastructure, composition, dissolution, and reconstitution. Neuron (2001) 3.68
Signal timing across the macaque visual system. J Neurophysiol (1998) 3.66
Msx2 deficiency in mice causes pleiotropic defects in bone growth and ectodermal organ formation. Nat Genet (2000) 3.64
The CLAVATA1 receptor-like kinase requires CLAVATA3 for its assembly into a signaling complex that includes KAPP and a Rho-related protein. Plant Cell (1999) 3.62
The Genome Knowledgebase: a resource for biologists and bioinformaticists. Cold Spring Harb Symp Quant Biol (2003) 3.55
A regulatory mechanism that detects premature nonsense codons in T-cell receptor transcripts in vivo is reversed by protein synthesis inhibitors in vitro. J Biol Chem (1995) 3.54
The alternative oxidase lowers mitochondrial reactive oxygen production in plant cells. Proc Natl Acad Sci U S A (1999) 3.53
Association of BRCA1 with the hRad50-hMre11-p95 complex and the DNA damage response. Science (1999) 3.47
The ica locus of Staphylococcus epidermidis encodes production of the capsular polysaccharide/adhesin. Infect Immun (1998) 3.44
Cooperative interaction of S. pombe proteins required for mating and morphogenesis. Cell (1994) 3.41
Focal adhesion kinase is involved in mechanosensing during fibroblast migration. Proc Natl Acad Sci U S A (2001) 3.41
A family of mammalian Na+-dependent L-ascorbic acid transporters. Nature (1999) 3.40
Oral ganciclovir for patients with cytomegalovirus retinitis treated with a ganciclovir implant. Roche Ganciclovir Study Group. N Engl J Med (1999) 3.38
Midzone microtubule bundles are continuously required for cytokinesis in cultured epithelial cells. J Cell Biol (1996) 3.36